Tern Therapeutics
PrivateLast Round
Series A
Aug 27, 2024
Total Funding Raised
$15M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Tern Therapeutics is a biotechnology company that develops transformative, one-time gene therapy medicines for rare diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Tern Therapeutics Comparables
Compare Tern Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Neela Therapeutics | 84% | |
| LEXEO Therapeutics | 80% | |
| Abeona Therapeutics Inc. | 78% | |
Tern Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Aug 27, 2024 |
Key People
Founding team and executive leadership
Tern Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| ATW Partners | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 15, 2026
Monthly visitors grew 111% MoM.
Tern Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Tern Therapeutics's valuation, stock price, and market status.